Replies to post #1342 on BioNeutral Group Inc. (fka BONU)

[ash111]

great info.and huge bids coming

[stervc]

Also, with the BONU CEO, Dr. Andy Kielbania…

I see that one of the companies you mentioned that the BONU CEO, Dr. Andy Kielbania, was with was Rohm and Haas which was a very huge multi-billion dollar company. In my opinion, him being here with BONU is a huge hint that he is not here because of something that could be considered small change. See below:

http://www.icis.com/v2/companies/9146143/rohm+and+haas.html
Rohm and Haas | Company Information from ICIS
In April 2009, Dow Chemical completed its $78/share takeover of Rohm and Haas. Dow Chemical will integrate its acquired Rohm and Haas business into the newly formed ‘Advanced Materials Division’ and will be headed by Pierre Brondeau.

So, Dow Chemical bought out Rohm and Haas for $78.00 per share. When you click on the old Rohm and Haas website, it takes you to Dow Chemicals website:
http://www.rohmhaas.com


For inquiring minds, Dow Chemicals trade on the NYSE at $40.00+ per shareunder the ticker pf DOW:
http://www.dow.com/


More proof that Dr. Andy Kielbania, PhD, CEO, Chief Scientific Officer and Director for BONU was an instrumental part of Rohm and Haas which was bought out by Dow Chemical:

http://webcache.googleusercontent.com/search?q=cache:2J2TxICDbCcJ:cdn-pubs.acs.org/doi/pdfplus/10.1021/bk-1990-0427.ch007+&cd=2&hl=en&ct=clnk&gl=us
At Rohm and Haas we thank Dr. Edward Firouztale, Dr. Peter Cartier, and Dr. Andy Kielbania for scholarly discussions and assistance with the research.

From your DD:

http://www.bioneutralgroup.com/management.html


v/r
Sterling

[lazyeye]

Kielbania is NOT the CEO. That title belongs to Mark Lowenthal.